What are the signs and symptoms of giant cell arteritis (GCA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Giant cell arteritis (GCA) typically presents with a combination of symptoms including headache, scalp tenderness, jaw claudication, visual disturbances, and systemic symptoms such as fever and fatigue, as supported by the most recent and highest quality study 1.

Key Symptoms

  • Headache: a new, severe headache, typically located in the temples, that doesn't respond well to over-the-counter pain medications
  • Scalp tenderness: particularly when combing hair or lying on a pillow
  • Jaw claudication: pain while chewing or talking, experienced by about half of patients
  • Visual disturbances: serious warning signs that may include blurred vision, double vision, or temporary or permanent vision loss
  • Systemic symptoms: fever, fatigue, unintentional weight loss, and general malaise

Importance of Prompt Recognition

Prompt recognition of GCA is crucial as delayed treatment can lead to permanent blindness. If GCA is suspected, immediate medical attention should be sought for evaluation, which typically includes blood tests for inflammatory markers and temporal artery biopsy, as recommended by recent guidelines 1.

Diagnostic Considerations

The diagnosis of GCA is based on clinical presentation, pathologic abnormalities on temporal artery biopsy, and/or evidence of large vessel involvement on vascular imaging. Imaging and biopsy have similar diagnostic value if assessors are proficient in these techniques, as noted in the 2020 update of the EULAR recommendations for the management of large vessel vasculitis 1.

Management

High-dose glucocorticoid therapy is the mainstay treatment for GCA, with a starting dose of 40-60 mg/day prednisone-equivalent, as recommended by the 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis 1. Tapering the glucocorticoid dose to a target dose of 15-20 mg/day within 2-3 months and after 1 year to ≤5 mg/day is recommended once disease is controlled.

From the Research

Signs and Symptoms of Giant Cell Arteritis (GCA)

The signs and symptoms of GCA include:

  • Headache, particularly bitemporal headaches 2, 3, 4, 5
  • Scalp tenderness or temporal artery tenderness 2, 3, 4, 5
  • Jaw claudication 2, 3, 4, 5
  • Polymyalgia rheumatica 2, 6, 3, 4
  • Visual disturbances, such as diplopia, amaurosis fugax, or blindness 2, 6, 3, 4, 5
  • Systemic symptoms, including fever, weight loss, and fatigue 3, 5
  • Musculoskeletal pain 5
  • Unusual clinical manifestations, such as lip, scalp, and tongue necrosis, carpal tunnel syndrome, claudication of the limbs, strokes, angina pectoris, myocardial infarction, hematuria, cough, or other CNS symptoms 5

Laboratory and Imaging Findings

Laboratory findings may include elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) 3, 4. Imaging studies, such as duplex sonography, high-resolution magnetic resonance imaging, and positron-emission tomography, may also be used to diagnose GCA 3. Temporal artery biopsy is considered the gold standard for diagnosis 4.

Importance of Early Recognition and Treatment

Early recognition and treatment of GCA are crucial to prevent irreversible complications, such as permanent vision loss 2, 6, 3, 4, 5. Prompt treatment with corticosteroids can improve symptoms and reduce the risk of complications 6, 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Giant cell arteritis presenting with uveitis.

Ocular immunology and inflammation, 2014

Research

The diagnosis and treatment of giant cell arteritis.

Deutsches Arzteblatt international, 2013

Research

Giant-cell arteritis.

The Journal of emergency medicine, 1986

Research

Treatment of giant cell arteritis.

Biochemical pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.